logo
Select company
Select metric
$ -102KNet Cash Flow - Issuance (Repayment) of Debt Securities
VS
Market
56
Sector
67
Industry
74
History
100
$ 1.21Close
$ 0.45 - $ 2.21 52-Week Range
Ticker Information

Ticker

KAPA

Company Name

KAIROS PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

KAIROS PHARMA LTD - Net Cash Flow - Issuance (Repayment) of Debt Securities Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KAPA - CF - Debt Historical data
DateNet Cash Flow - Issuance (Repayment) of Debt Securities
6/30/2025$ -102K
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 142K
12/31/2023$ 0
12/31/2022$ 774K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KAIROS PHARMA LTD's latest trailing twelve months (TTM) CF - Debt stands at $ 774K.
  • Over the past 5 years, KAIROS PHARMA LTD's average CF - Debt has been $ 135.67K.
  • The median CF - Debt for KAIROS PHARMA LTD during this period was $ 0
  • KAIROS PHARMA LTD reached its highest CF - Debt over the past 5 years at $ 774K.
  • The lowest CF - Debt recorded by KAIROS PHARMA LTD in the same timeframe $ -102K

Definition of Net Cash Flow - Issuance (Repayment) of Debt Securities

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.

KAPA - Net Cash Flow - Issuance (Repayment) of Debt Securities, Last 5 years

$ -102K

Minimum

Jun 30, 2025

$ 774K

Maximum

Dec 31, 2022

$ 135.67K

Average

$ 0

Median

CF - Debt Benchmark Analysis

The chart above depicts the distribution of CF - Debt for companies in the Total Stock Market. The average CF - Debt of the companies is $ -1.68M with a standard deviation of $ 24.18M.
The following table provides additional summary stats:
CF - Debt in the Market:
filtered constituents2.85K
min$ -84.35M
max$ 83.81M
average$ -1.68M
median$ 0
std$ 24.18M